PUBLISHER: The Insight Partners | PRODUCT CODE: 1494340
PUBLISHER: The Insight Partners | PRODUCT CODE: 1494340
The North America implantable medical devices market is expected to grow from US$ 30,170.24 million in 2022 to US$ 52,330.44 million by 2030. It is estimated to grow at a CAGR of 7.1% from 2022 to 2030.
Growing Use of 3D Printing Technology Devices Fuel the North America Implantable Medical Devices Market
North America Implantable Medical Devices Market Overview
The North America Implantable Medical Devices Market is segmented into the US, Canada, and Mexico. North America is expected to hold a significant share of the global market during the forecast period due to the increasing prevalence of neurological diseases, cardiovascular diseases (CVD), breast cancer, technological advancement, and high spending on research and development. The rising geriatric population prone to neurological diseases is expected to offer lucrative opportunities for market growth in the region during the forecast period.
North America Implantable Medical Devices Market Revenue and Forecast to 2030 (US$ Million)
North America Implantable Medical Devices Market Segmentation
The North America implantable medical devices market is segmented into implant type, product type, material type, application, end user and country.
Based on implant type, the North America implantable medical devices market is bifurcated into active implant & passive implant. The passive implant segment held a larger share of the North America implantable medical devices market in 2022.
Based on product type, the North America implantable medical devices market is bifurcated into diagnostic & treatment. The treatment segment held a larger share of the North America implantable medical devices market in 2022.
Based on material type, the North America implantable medical devices market is segmented into metallic, ceramic, and polymers. The metallic segment held the largest share of the North America implantable medical devices market in 2022.
Based on application, the North America implantable medical devices market is segmented into dental implants, orthopedic implants, cardiovascular implants, breast implants, brain implants, and others. The orthopedic implants segment held the largest share of the North America implantable medical devices market in 2022.
Based on end user, the North America implantable medical devices market is segmented into hospitals, specialty clinics, ASCs, and others. The hospitals segment held the largest share of the North America implantable medical devices market in 2022.
Based on country, the North America implantable medical devices market is segmented into the US, Canada, and Mexico. The US dominated the North America implantable medical devices market in 2022.
Abbott Laboratories, Boston Scientific Corp, Dentsply Sirona Inc, Johnson & Johnson, Medtronic Plc, Institut Straumann AG, Smith & Nephew Plc, Biotronik SE & Co KG, LivaNova Plc, and MED-EL Elektromedizin Gerate Gesellschaft mbH are some of the leading companies operating in the North America implantable medical devices market.